4qaz Citations

The structure of the C-terminal domain of the Zaire ebolavirus nucleoprotein.

Acta Crystallogr D Biol Crystallogr 70 2420-9 (2014)
Cited: 29 times
EuropePMC logo PMID: 25195755

Abstract

Ebolavirus (EBOV) causes severe hemorrhagic fever with a mortality rate of up to 90%. EBOV is a member of the order Mononegavirales and, like other viruses in this taxonomic group, contains a negative-sense single-stranded (ss) RNA. The EBOV ssRNA encodes seven distinct proteins. One of them, the nucleoprotein (NP), is the most abundant viral protein in the infected cell and within the viral nucleocapsid. Like other EBOV proteins, NP is multifunctional. It is tightly associated with the viral genome and is essential for viral transcription, RNA replication, genome packaging and nucleocapsid assembly prior to membrane encapsulation. NP is unusual among the Mononegavirales in that it contains two distinct regions, or putative domains, the C-terminal of which shows no homology to any known proteins and is purported to be a hub for protein-protein interactions within the nucleocapsid. The atomic structure of NP remains unknown. Here, the boundaries of the N- and C-terminal domains of NP from Zaire EBOV are defined, it is shown that they can be expressed as highly stable recombinant proteins in Escherichia coli, and the atomic structure of the C-terminal domain (residues 641-739) derived from analysis of two distinct crystal forms at 1.98 and 1.75 Å resolution is described. The structure reveals a novel tertiary fold that is distantly reminiscent of the β-grasp architecture.

Articles - 4qaz mentioned but not cited (11)

  1. The structure of the C-terminal domain of the Zaire ebolavirus nucleoprotein. Dziubańska PJ, Derewenda U, Ellena JF, Engel DA, Derewenda ZS. Acta Crystallogr D Biol Crystallogr 70 2420-2429 (2014)
  2. Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis. Xu W, Luthra P, Wu C, Batra J, Leung DW, Basler CF, Amarasinghe GK. Nat Commun 8 15576 (2017)
  3. Ebolavirus is evolving but not changing: No evidence for functional change in EBOV from 1976 to the 2014 outbreak. Olabode AS, Jiang X, Robertson DL, Lovell SC. Virology 482 202-207 (2015)
  4. Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach. Baikerikar S. Pharmacognosy Res 9 S15-S22 (2017)
  5. Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses. Baker LE, Ellena JF, Handing KB, Derewenda U, Utepbergenov D, Engel DA, Derewenda ZS. Acta Crystallogr D Struct Biol 72 49-58 (2016)
  6. Predictive and comparative analysis of Ebolavirus proteins. Cong Q, Pei J, Grishin NV. Cell Cycle 14 2785-2797 (2015)
  7. Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription. Ivanov A, Ramanathan P, Parry C, Ilinykh PA, Lin X, Petukhov M, Obukhov Y, Ammosova T, Amarasinghe GK, Bukreyev A, Nekhai S. Cell Mol Life Sci 77 2579-2603 (2020)
  8. Characterizing alpha helical properties of Ebola viral proteins as potential targets for inhibition of alpha-helix mediated protein-protein interactions. Chakraborty S, Rao BJ, Asgeirsson B, Dandekar A. F1000Res 3 251 (2014)
  9. Backbone resonance assignments and secondary structure of Ebola nucleoprotein 600-739 construct. Lee W, Tonelli M, Wu C, Aceti DJ, Amarasinghe GK, Markley JL. Biomol NMR Assign 13 315-319 (2019)
  10. Fragment screening targeting Ebola virus nucleoprotein C-terminal domain identifies lead candidates. Aceti DJ, Ahmed H, Westler WM, Wu C, Dashti H, Tonelli M, Eghbalnia H, Amarasinghe GK, Markley JL. Antiviral Res 180 104822 (2020)
  11. Structural insights on the nucleoprotein C-terminal domain of Měnglà virus. Ferrero DS, Tomás Gilabert O, Verdaguer N. Microbiol Spectr 11 e0237323 (2023)


Reviews citing this publication (4)

  1. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle. Martin B, Canard B, Decroly E. Antiviral Res 141 48-61 (2017)
  2. Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion. Pleet ML, DeMarino C, Stonier SW, Dye JM, Jacobson S, Aman MJ, Kashanchi F. Viruses 11 E410 (2019)
  3. Assembly and transport of filovirus nucleocapsids. Dolnik O, Becker S. PLoS Pathog 18 e1010616 (2022)
  4. Ebola virus - from neglected threat to global emergency state. Pacheco DA, Rodrigues AA, Silva CM. Rev Assoc Med Bras (1992) 62 458-467 (2016)

Articles citing this publication (14)